F
Frédéric Charlotte
Researcher at University of Paris
Publications - 315
Citations - 27482
Frédéric Charlotte is an academic researcher from University of Paris. The author has contributed to research in topics: Liver biopsy & Histiocytosis. The author has an hindex of 75, co-authored 295 publications receiving 24972 citations. Previous affiliations of Frédéric Charlotte include Centre national de la recherche scientifique & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Maladie d'Erdheim-Chester: étude monocentrique de 24 patients
J. Haroche,Z. Amoura,Frédéric Charlotte,L. Gambotti,B. Wechsler,Patrice Cacoub,N. Costedoat-Chalumeau,Philippe Cluzel,Philippe Grenier,J.C. Piette +9 more
Journal ArticleDOI
Prevalence, patterns and outcomes of cardiac involvement in Erdheim-Chester disease.
Levi-Dan Azoulay,Marine Bravetti,Fleur Cohen-Aubart,Jean-François Emile,Danielle Seilhean,Isabelle Plu,Frédéric Charlotte,Xavier Waintraub,Fabrice Carrat,Zahir Amoura,Philippe Cluzel,Julien Haroche +11 more
TL;DR: In this paper , the authors investigated the prevalence, clinical features, imaging features, and prognosis of cardiac involvement in Erdheim-Chester disease in a large series of patients.
Journal ArticleDOI
Immunological environment in colorectal cancer: a computer-aided morphometric study of whole slide digital images derived from tissue microarray.
Daniel Eyraud,Benjamin Granger,Armelle Bardier,Yann Loncar,GaËlle Gottrand,Gilles Le Naour,Jean-Michel Siksik,Jean-Christophe Vaillant,David Klatzmann,Louis Puybasset,Frédéric Charlotte,Jérémy Augustin +11 more
TL;DR: The cellular infiltrate of colorectal cancer (CRC) was assessed using computer-aided analysis of whole slide digital image derived from tissue microarray (TMA) and the proportion of IDO+ tissue areas in the lamina propria or in the non-epithelial area of the lymph node and in epithelial cells in each site was analysed.
Journal ArticleDOI
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
Audrey Moatti,Anais Debesset,Caroline Pilon,Asma Beldi-Ferchiou,Mathieu Leclerc,Rabah Redjoul,Frédéric Charlotte,Nhu Hanh To,Adeline Bak,Yazid Belkacemi,Benoît L. Salomon,Fadi Issa,David Michonneau,Sébastien Maury,José L. Cohen,Allan Thiolat +15 more
TL;DR: TNFR2 is highlighted as a new target molecule for the development of immunotherapies to treat blood malignancy relapse, used either directly in grafted patients or to enhance donor lymphocyte infusion strategies.